{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:09:36Z","timestamp":1788480576452,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["2019T067"],"award-info":[{"award-number":["2019T067"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["114024185"],"award-info":[{"award-number":["114024185"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejphar.2025.178336","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:12:51Z","timestamp":1762416771000},"page":"178336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Modulation of IL-1, IL-6 and IL-18 cytokine signaling in animal models of atherosclerosis: a systematic review evaluating animal sex in preclinical research"],"prefix":"10.1016","volume":"1008","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1018-191X","authenticated-orcid":false,"given":"Lucie","family":"Delfos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1205-0546","authenticated-orcid":false,"given":"Cody","family":"Huis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-4899-4759","authenticated-orcid":false,"given":"Nadia","family":"Imani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6870-9962","authenticated-orcid":false,"given":"Jeanine E.","family":"Roeters van Lennep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-5714","authenticated-orcid":false,"given":"Carlijn R.","family":"Hooijmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1242-1959","authenticated-orcid":false,"given":"Ilze","family":"Bot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178336_bib1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","article-title":"Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE 2.Ki mice fed a high-fat diet","volume":"131","author":"Abderrazak","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178336_bib2","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/ATVBAHA.124.320155","article-title":"Inflammation and atherosclerosis: prospects for clinical trials","volume":"44","author":"Ait-Oufella","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fcvm.2017.00084","article-title":"An Interleukin-6 receptor antibody suppresses atherosclerosis in atherogenic mice","volume":"4","author":"Akita","year":"2017","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.ejphar.2025.178336_bib4","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.178336_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2011.02.026","article-title":"Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in apolipoprotein E-deficient mice","volume":"216","author":"Bhaskar","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2025.178336_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jjcc.2014.10.012","article-title":"Interleukin-18-induced atherosclerosis involves CD36 and NF-\u03baB crosstalk in Apo E-\/- mice","volume":"66","author":"Bhat","year":"2015","journal-title":"J. Cardiol."},{"key":"10.1016\/j.ejphar.2025.178336_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s10787-017-0357-9","article-title":"Terminalia arjuna prevents Interleukin-18-induced atherosclerosis via modulation of NF-\u03baB\/PPAR-\u03b3-mediated pathway in Apo E\u2212\/\u2212 mice","volume":"26","author":"Bhat","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.ejphar.2025.178336_bib8","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bjorkegren","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178336_bib9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1600-0765.2008.01156.x","article-title":"Gender differences in systemic inflammation and atheroma formation following Porphyromonas gingivalis infection in heterozygous apolipoprotein E-deficient mice","volume":"44","author":"Champagne","year":"2009","journal-title":"J. Periodontal. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib10","article-title":"Interleukin 6-regulated macrophage polarization controls atherosclerosis-associated vascular intimal hyperplasia","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178336_bib11","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1161\/ATVBAHA.112.249417","article-title":"Marked acceleration of atherosclerosis after lactobacillus casei-induced coronary arteritis in a mouse model of Kawasaki disease","volume":"32","author":"Chen","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib12","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.atherosclerosis.2011.08.051","article-title":"Estrogen-dependent activation of neutral cholesterol ester hydrolase underlying gender difference of atherogenesis in apoE -\/- mice","volume":"219","author":"Chiba","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2025.178336_bib13","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1093\/eurheartj\/ehz206","article-title":"Prevention of radiotherapy-induced arterial inflammation by interleukin-1 blockade","volume":"40","author":"Christersdottir","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2025.178336_bib14","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1161\/ATV.0000000000000062","article-title":"Recommendation on design, execution, and reporting of animal atherosclerosis studies: a scientific statement from the American heart Association","volume":"37","author":"Daugherty","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib15","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.ATV.0000147126.99529.0a","article-title":"Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice","volume":"24","author":"de Nooijer","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.112.002006","article-title":"Interleukin\u20101 mediates neuroinflammatory changes associated with diet\u2010induced atherosclerosis","volume":"1","author":"Denes","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ejphar.2025.178336_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cti2.1206","article-title":"Inhibition of interleukin-1\u03b2 signalling promotes atherosclerotic lesion remodelling in mice with inflammatory arthritis","volume":"9","author":"Dragoljevic","year":"2020","journal-title":"Clinical and Translational Immunology"},{"key":"10.1016\/j.ejphar.2025.178336_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104849","article-title":"Enduring effects of early-life adversity on reward processes: a systematic review and meta-analysis of animal studies","volume":"142","author":"Duque-Quintero","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejphar.2025.178336_bib19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1161\/01.CIR.97.3.242","article-title":"Differential effects of interleukin-1 receptor antagonist and tumor necrosis factor binding protein on fatty-streak formation in apolipoprotein E-deficient mice","volume":"97","author":"Elhage","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178336_bib20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(21)00249-X","article-title":"Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study","volume":"397","author":"Erlinge","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2025.178336_bib21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178336_bib22","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/eji.201041316","article-title":"Nrf 2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis","volume":"41","author":"Freigang","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2025.178336_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/00005344-199702000-00011","article-title":"Inflammatory cytokines cause coronary arteriosclerosis-like changes and alterations in the smooth-muscle phenotypes in pigs","volume":"29","author":"Fukumoto","year":"1997","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178336_bib24","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178336_bib25","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1161\/CIRCRESAHA.122.320263","article-title":"Animal models of atherosclerosis\u2013supportive notes and tricks of the trade","volume":"130","author":"Gister\u00e5","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib26","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1038\/s41591-018-0124-5","article-title":"Interleukin-1\u03b2 has atheroprotective effects in advanced atherosclerotic lesions of mice","volume":"24","author":"Gomez","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.178336_bib27","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/01.ATV.6.2.155","article-title":"Development of Coronary Atherosclerosis in Swine with Severe Hypercholesterolemia - lack of Influence of von Willebrand Factor or Acute Intimal Injury","volume":"6","author":"Griggs","year":"1986","journal-title":"Arteriosclerosis"},{"key":"10.1016\/j.ejphar.2025.178336_bib28","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1093\/cvr\/cvab337","article-title":"Interleukin-1\u00df suppression dampens inflammatory leucocyte production and uptake in atherosclerosis","volume":"118","author":"Hettwer","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114634","article-title":"Pharmacological inhibition of fatty acid oxidation reduces atherosclerosis progression by suppression of macrophage NLRP3 inflammasome activation","volume":"190","author":"Hohensinner","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178336_bib30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.ejphar.2025.178336_bib31","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.5551\/jat.7567","article-title":"Proatherogenic effect of interleukin-18 is exerted with high-fat diet, but not with normal diet in spontaneously hyperlipidemic mice","volume":"18","author":"Imai","year":"2011","journal-title":"J. Atherosclerosis Thromb."},{"key":"10.1016\/j.ejphar.2025.178336_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density Lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178336_bib33","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1172\/JCI117179","article-title":"Massive xanthomatosis and atherosclerosis in cholesterol-fed low density Lipoprotein receptor-negative mice","volume":"93","author":"Ishibashi","year":"1994","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178336_bib34","first-page":"1071","article-title":"Acute perioperative-stress-induced increase of atherosclerotic plaque volume and vulnerability to rupture in apolipoprotein-E-deficient mice is amenable to statin treatment and IL-6 inhibition","volume":"8","author":"Janssen","year":"2015","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.ejphar.2025.178336_bib35","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1161\/CIRCULATIONAHA.109.882704","article-title":"CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice","volume":"121","author":"Jeon","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178336_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.atherosclerosis.2023.03.004","article-title":"Serum amyloid A and interleukin -1\u03b2 facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-\u03baB\/caveolin-1\/cavin-1 pathway","volume":"375","author":"Jia","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2025.178336_bib37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41419-022-04966-8","article-title":"Novel role for caspase 1 inhibitor VX765 in suppressing NLRP3 inflammasome assembly and atherosclerosis via promoting mitophagy and efferocytosis","volume":"13","author":"Jin","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2025.178336_bib38","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1161\/ATVBAHA.124.320800","article-title":"IL-1\u03b2 Inhibition partially negates the beneficial effects of diet-induced atherosclerosis regression in mice","volume":"44","author":"Karnewar","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms23094906","article-title":"The anti\u2010atherosclerosis effect of anakinra, a recombinant human Interleukin\u20101 receptor antagonist, in apolipoprotein E knockout mice","volume":"23","author":"Ku","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2025.178336_bib40","first-page":"1","article-title":"Cytotoxin-associated gene A (CagA) promotes aortic endothelial inflammation and accelerates atherosclerosis through the NLRP3\/caspase-1\/IL-1\u03b2 axis","volume":"35","author":"Li","year":"2021","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.ejphar.2025.178336_bib41","first-page":"1393","article-title":"Tacrolimus reduces atherosclerotic plaque formation in ApoE-\/- mice by inhibiting NLRP3 inflammatory corpuscles","volume":"19","author":"Li","year":"2020","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ejphar.2025.178336_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2020.111847","article-title":"VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis","volume":"389","author":"Li","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib43","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","article-title":"The changing landscape of atherosclerosis","volume":"592","author":"Libby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2025.178336_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107990","article-title":"Macrophage K63-Linked ubiquitination of YAP promotes its nuclear localization and exacerbates atherosclerosis","volume":"32","author":"Liu","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2025.178336_bib45","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbrc.2015.11.064","article-title":"Impact of age and sex on the development of atherosclerosis and expression of the related genes in apoE deficient mice","volume":"469","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2025.178336_bib46","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s44161-023-00281-3","article-title":"Blockade of IL-6 signaling alleviates atherosclerosis in Tet2-deficient clonal hematopoiesis","volume":"2","author":"Liu","year":"2023","journal-title":"Nature Cardiovascular Research"},{"key":"10.1016\/j.ejphar.2025.178336_bib47","first-page":"1398","article-title":"Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport","volume":"34","author":"Luo","year":"2020","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.ejphar.2025.178336_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118304","article-title":"Raloxifene inhibits IL-6\/STAT3 signaling pathway and protects against high-fat-induced atherosclerosis in ApoE\u2212\/\u2212 mice","volume":"261","author":"Luo","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.178336_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173822","article-title":"Bazedoxifene exhibits anti-inflammation and anti-atherosclerotic effects via inhibition of IL-6\/IL-6R\/STAT3 signaling","volume":"893","author":"Luo","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178336_bib50","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bph.15949","article-title":"Repurposing nitazoxanide as a novel anti-atherosclerotic drug based on mitochondrial uncoupling mechanisms","volume":"180","author":"Ma","year":"2023","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.178336_bib51","first-page":"4971","article-title":"Hypoxia-inducible protein 2 Hig2\/Hilpda mediates neutral lipid accumulation in macrophages and contributes to atherosclerosis in apolipoprotein E-deficient mice","volume":"31","author":"Maier","year":"2017","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.ejphar.2025.178336_bib52","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/hh1901.098735","article-title":"Interleukin-18\/interleukin-18 binding protein signaling modulates atherosclerotic lesion development and stability","volume":"89","author":"Mallat","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib53","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/CIRCRESAHA.120.315930","article-title":"Sex as a biological variable in atherosclerosis","volume":"126","author":"Man","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13293-017-0141-y","article-title":"Sex differences in the development of vascular and renal lesions in mice with a simultaneous deficiency of Apoe and the integrin chain Itga8","volume":"8","author":"Marek","year":"2017","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.ejphar.2025.178336_bib55","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1161\/ATVBAHA.115.306848","article-title":"Overexpression of cytotoxic T-lymphocyte-associated antigen-4 prevents atherosclerosis in mice","volume":"36","author":"Matsumoto","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jcmg.2012.01.005","article-title":"Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention","volume":"5","author":"McPherson","year":"2012","journal-title":"JACC, Cardiovasc. Imaging"},{"key":"10.1016\/j.ejphar.2025.178336_bib57","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.bbrc.2016.03.059","article-title":"RIP3-dependent necrosis induced inflammation exacerbates atherosclerosis","volume":"473","author":"Meng","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2025.178336_bib58","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.jid.2023.09.269","article-title":"Kinetics of inflammatory mediators in the immune response to burn injury: systematic review and meta-analysis of animal studies","volume":"144","author":"Mulder","year":"2024","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.ejphar.2025.178336_bib59","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-Dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.ejphar.2025.178336_bib60","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178336_bib61","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.abg3067","article-title":"Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production","volume":"375","author":"Orecchioni","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178336_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.ejphar.2025.178336_bib63","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2025.178336_bib64","article-title":"PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Br. Med. J."},{"key":"10.1016\/j.ejphar.2025.178336_bib65","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0021-9150(87)90249-8","article-title":"Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL\/6, BALB\/c, and C3H","volume":"64","author":"Paigen","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2025.178336_bib66","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1161\/01.ATV.0000246774.02426.71","article-title":"Loss of the lysophosphatidylcholine effector, G2A, ameliorates aortic atherosclerosis in low-density lipoprotein receptor knockout mice","volume":"26","author":"Parks","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib67","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-G","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-Deficient mice created by homologous recombination in ES cells","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2025.178336_bib68","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/17584299.2017.1319787","article-title":"Interleukin-6 in atherosclerosis: atherogenic or atheroprotective?","volume":"12","author":"Reiss","year":"2017","journal-title":"Clin. Lipidol."},{"key":"10.1016\/j.ejphar.2025.178336_bib69","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejphar.2025.178336_bib70","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.ejphar.2025.178336_bib71","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178336_bib72","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178336_bib73","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib74","article-title":"Colchicine exerts anti-atherosclerotic and -plaque-stabilizing effects targeting foam cell formation","volume":"37","author":"Schwarz","year":"2023","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.ejphar.2025.178336_bib75","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.echo.2020.11.012","article-title":"Echocardiographic molecular imaging of the effect of anti-cytokine therapy for atherosclerosis","volume":"34","author":"Shentu","year":"2021","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ejphar.2025.178336_bib76","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1172\/JCI118476","article-title":"Chronic treatment with interleukin-1\u03b2 induces coronary intimal lesions and vasospastic responses in pigs in vivo - the role of platelet-derived growth factor","volume":"97","author":"Shimokawa","year":"1996","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178336_bib77","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0008-6363(01)00291-7","article-title":"Long-term inhibition of rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo","volume":"51","author":"Shimokawa","year":"2001","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib78","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.ATV.0000075947.28567.50","article-title":"Development of an animal model for spontaneous myocardial infarction (WHHLMI rabbit)","volume":"23","author":"Shiomi","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12979-024-00434-3","article-title":"Sexual dimorphism in atherosclerotic plaques of aged Ldlr\u2212\/\u2212 mice","volume":"21","author":"Smit","year":"2024","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.ejphar.2025.178336_bib80","first-page":"7765","article-title":"The effect of per os colchicine administration in combination with fenofibrate and N-acetylcysteine on triglyceride levels and the development of atherosclerotic lesions in cholesterol-fed rabbits","volume":"25","author":"Spartalis","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2025.178336_bib81","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history Study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178336_bib82","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.ATV.0000214296.94849.1c","article-title":"Synthetic retinoid Am80 reduces scavenger receptor expression and atherosclerosis in mice by inhibiting IL-6","volume":"26","author":"Takeda","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib83","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1016\/S0022-2275(20)39713-3","article-title":"Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice","volume":"36","author":"Tangirala","year":"1995","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.ejphar.2025.178336_bib84","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/01.ATV.0000153516.02782.65","article-title":"IL-18 accelerates atherosclerosis accompanied by elevation of IFN-\u03b3 and CXCL16 expression independently of T cells","volume":"25","author":"Tenger","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib85","doi-asserted-by":"crossref","first-page":"9992","DOI":"10.1002\/jcp.29813","article-title":"Interleukin-36 receptor antagonist attenuates atherosclerosis development by inhibiting NLRP3 inflammasome","volume":"235","author":"Tian","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2025.178336_bib86","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/eji.201242687","article-title":"A VLP-based vaccine against interleukin-1\u03b1 protects mice from atherosclerosis","volume":"43","author":"Tissot","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2025.178336_bib87","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cyto.2006.05.007","article-title":"Manipulation of inflammation modulates hyperlipidemia in apolipoprotein E-deficient mice: a possible role for interleukin-6","volume":"34","author":"Tous","year":"2006","journal-title":"Cytokine"},{"key":"10.1016\/j.ejphar.2025.178336_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106453","article-title":"Impavido attenuates inflammation, reduces atherosclerosis, and alters gut microbiota in hyperlipidemic mice","volume":"26","author":"Traughber","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.ejphar.2025.178336_bib89","doi-asserted-by":"crossref","first-page":"10540","DOI":"10.1016\/S0021-9258(18)82232-3","article-title":"Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia","volume":"268","author":"van den Maagdenberg","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2025.178336_bib90","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein E-Deficient mice - brief report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib91","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jcmg.2024.12.004","article-title":"Vulnerable or high-risk plaque: a JACC: cardiovascular imaging position statement","volume":"18","author":"Vergallo","year":"2025","journal-title":"JACC, Cardiovasc. Imaging"},{"key":"10.1016\/j.ejphar.2025.178336_bib92","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1093\/eurheartj\/ehz008","article-title":"Stage-dependent differential effects of interleukin-1 isoforms on experimental atherosclerosis","volume":"40","author":"Vromman","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ejphar.2025.178336_bib93","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2147\/DMSO.S222053","article-title":"NLRP3 inflammasome promotes diabetes-induced endothelial inflammation and atherosclerosis","volume":"12","author":"Wan","year":"2019","journal-title":"Diabetes, Metab. Syndrome Obes. Targets Ther."},{"key":"10.1016\/j.ejphar.2025.178336_bib94","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s12020-020-02389-z","article-title":"Thioredoxin-1 attenuates atherosclerosis development through inhibiting NLRP3 inflammasome","volume":"70","author":"Wang","year":"2020","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.ejphar.2025.178336_bib95","doi-asserted-by":"crossref","first-page":"910","DOI":"10.18632\/aging.202202","article-title":"Tanshinone IIA attenuates atherosclerosis via inhibiting NLRP3 inflammasome activation","volume":"13","author":"Wen","year":"2021","journal-title":"Aging"},{"key":"10.1016\/j.ejphar.2025.178336_bib96","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.ATV.0000243925.65265.3c","article-title":"Cholesteryl Ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE\u22173-Leiden mice","volume":"26","author":"Westerterp","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib97","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1161\/hh0202.105292","article-title":"Interleukin-18 enhances atherosclerosis in apolipoprotein E(-\/-) mice through release of interferon-gamma","volume":"90","author":"Whitman","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106043","article-title":"Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE-\/- mice","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2021.105974","article-title":"SNF5 promotes IL-1\u03b2 expression via H3K4me1 in atherosclerosis induced by homocysteine","volume":"135","author":"Xie","year":"2021","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib100","first-page":"1","article-title":"circDENND1B participates in the antiatherosclerotic effect of IL-1\u03b2 monoclonal antibody in mouse by promoting cholesterol efflux via miR-17-5p\/Abca1 axis","volume":"9","author":"Xu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2025.178336_bib101","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jconrel.2023.01.024","article-title":"A metal-organic framework-based immunomodulatory nanoplatform for anti-atherosclerosis treatment","volume":"354","author":"Xu","year":"2023","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejphar.2025.178336_bib102","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cvr\/cvac189","article-title":"Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1\u03b2 secretion","volume":"119","author":"Yalcinkaya","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib103","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.biopha.2018.01.145","article-title":"Sex differences in the formation of atherosclerosis lesion in apoE-\/-mice and the effect of 17\u03b2-estrodiol on protein S-nitrosylation","volume":"99","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178336_bib104","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.abb.2012.09.007","article-title":"Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase \u03b11 via a mitogen-activated protein kinase and c-Jun pathway","volume":"528","author":"Zhang","year":"2012","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2025.178336_bib105","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2025.178336_bib106","doi-asserted-by":"crossref","DOI":"10.1177\/1479164120977441","article-title":"Baicalin ameliorates atherosclerosis by inhibiting NLRP3 inflammasome in apolipoprotein E-deficient mice","volume":"17","author":"Zhao","year":"2020","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"10.1016\/j.ejphar.2025.178336_bib107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7554\/eLife.24260","article-title":"Standardized mean differences cause funnel plot distortion in publication bias assessments","volume":"6","author":"Zwetsloot","year":"2017","journal-title":"eLife"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925010908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:03:45Z","timestamp":1773824625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925010908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":107,"alternative-id":["S0014299925010908"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178336","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulation of IL-1, IL-6 and IL-18 cytokine signaling in animal models of atherosclerosis: a systematic review evaluating animal sex in preclinical research","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"178336"}}